These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex. Lerma LA; Schade GR; Tretiakova MS Hum Pathol; 2021 Oct; 116():1-11. PubMed ID: 34153307 [TBL] [Abstract][Full Text] [Related]
4. Malignant tumors in tuberous sclerosis complex: a case report and review of the literature. Liu C; Lele SM; Goodenberger MH; Reiser GM; Christiansen AJ; Padussis JC BMC Med Genomics; 2024 May; 17(1):144. PubMed ID: 38802873 [TBL] [Abstract][Full Text] [Related]
5. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Lam HC; Siroky BJ; Henske EP Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410 [TBL] [Abstract][Full Text] [Related]
6. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. Mehra R; Vats P; Cao X; Su F; Lee ND; Lonigro R; Premkumar K; Trpkov K; McKenney JK; Dhanasekaran SM; Chinnaiyan AM Eur Urol; 2018 Oct; 74(4):483-486. PubMed ID: 29941307 [TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314 [TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis complex and DNA repair. Habib SL Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497 [TBL] [Abstract][Full Text] [Related]
9. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727 [TBL] [Abstract][Full Text] [Related]
11. TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : A Targeted Next-generation Sequencing and Gene Expression Profiling Study. Xia QY; Wang XT; Zhao M; He HY; Fang R; Ye SB; Li R; Wang X; Zhang RS; Lu ZF; Ma HH; Wang ZY; Rao Q Am J Surg Pathol; 2022 Nov; 46(11):1562-1576. PubMed ID: 35980750 [TBL] [Abstract][Full Text] [Related]
12. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting. Kapur P; Brugarolas J; Trpkov K Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627070 [TBL] [Abstract][Full Text] [Related]
17. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum. Palsgrove DN; Li Y; Pratilas CA; Lin MT; Pallavajjalla A; Gocke C; De Marzo AM; Matoso A; Netto GJ; Epstein JI; Argani P Am J Surg Pathol; 2018 Sep; 42(9):1166-1181. PubMed ID: 29975249 [TBL] [Abstract][Full Text] [Related]
18. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked? Henske EP Curr Mol Med; 2004 Dec; 4(8):825-31. PubMed ID: 15579029 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations. Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150 [TBL] [Abstract][Full Text] [Related]
20. Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up. Shah RB; Mehra R Adv Anat Pathol; 2024 Mar; 31(2):105-117. PubMed ID: 37899532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]